199 related articles for article (PubMed ID: 24349314)
1. Cost-effectiveness analysis of breast cancer control interventions in Peru.
Zelle SG; Vidaurre T; Abugattas JE; Manrique JE; Sarria G; Jeronimo J; Seinfeld JN; Lauer JA; Sepulveda CR; Venegas D; Baltussen R
PLoS One; 2013; 8(12):e82575. PubMed ID: 24349314
[TBL] [Abstract][Full Text] [Related]
2. Costs, effects and cost-effectiveness of breast cancer control in Ghana.
Zelle SG; Nyarko KM; Bosu WK; Aikins M; Niëns LM; Lauer JA; Sepulveda CR; Hontelez JA; Baltussen R
Trop Med Int Health; 2012 Aug; 17(8):1031-43. PubMed ID: 22809238
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of breast cancer control strategies in Central America: the cases of Costa Rica and Mexico.
Niëns LM; Zelle SG; Gutiérrez-Delgado C; Rivera Peña G; Hidalgo Balarezo BR; Rodriguez Steller E; Rutten FF
PLoS One; 2014; 9(4):e95836. PubMed ID: 24769920
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
6. Cost-Effectiveness Analysis of Breast Cancer Screening in Rural Iran.
Zehtab N; Jafari M; Barooni M; Nakhaee N; Goudarzi R; Larry Zadeh MH
Asian Pac J Cancer Prev; 2016; 17(2):609-14. PubMed ID: 26925651
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of norovirus vaccination in children in Peru.
Mirelman AJ; Ballard SB; Saito M; Kosek MN; Gilman RH
Vaccine; 2015 Jun; 33(27):3084-91. PubMed ID: 25980428
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.
Geuzinge HA; Obdeijn IM; Rutgers EJT; Saadatmand S; Mann RM; Oosterwijk JC; Tollenaar RAEM; de Roy van Zuidewijn DBW; Lobbes MBI; van 't Riet M; Hooning MJ; Ausems MGEM; Loo CE; Wesseling J; Luiten EJT; Zonderland HM; Verhoef C; Heijnsdijk EAM; Tilanus-Linthorst MMA; de Koning HJ;
JAMA Oncol; 2020 Sep; 6(9):1381-1389. PubMed ID: 32729887
[TBL] [Abstract][Full Text] [Related]
9. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Screening in Georgia: Choosing the Most Optimal and Cost-Effective Strategy.
Irzaldy A; Gvamichava R; Beruchashvili T; Sturua L; van Ravesteyn NT; de Koning HJ; Heijnsdijk EAM
Value Health Reg Issues; 2024 Jan; 39():66-73. PubMed ID: 37992568
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of malaria control in sub-Saharan Africa.
Goodman CA; Coleman PG; Mills AJ
Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
Kuznik A; Habib AG; Munube D; Lamorde M
BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
[TBL] [Abstract][Full Text] [Related]
14. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
Shen Y; Parmigiani G
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania.
Gilson L; Mkanje R; Grosskurth H; Mosha F; Picard J; Gavyole A; Todd J; Mayaud P; Swai R; Fransen L; Mabey D; Mills A; Hayes R
Lancet; 1997 Dec 20-27; 350(9094):1805-9. PubMed ID: 9428251
[TBL] [Abstract][Full Text] [Related]
16. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
17. Assessing the Cost-Effectiveness of Updated Breast Cancer Screening Guidelines for Average-Risk Women.
Tina Shih YC; Dong W; Xu Y; Shen Y
Value Health; 2019 Feb; 22(2):185-193. PubMed ID: 30711063
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
Mohan G; Chattopadhyay S
JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
[TBL] [Abstract][Full Text] [Related]
19. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation : A Comparative Modeling Study.
Yeh JM; Lowry KP; Schechter CB; Diller LR; Alagoz O; Armstrong GT; Hampton JM; Leisenring W; Liu Q; Mandelblatt JS; Miglioretti DL; Moskowitz CS; Oeffinger KC; Trentham-Dietz A; Stout NK
Ann Intern Med; 2020 Sep; 173(5):331-341. PubMed ID: 32628531
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]